We have completed 31 of 40 patients in a NIDA sponsored double-blind RTC study (Grant #1R43DA050358-01), which has been temporarily interrupted by the pandemic, but to date shows a highly significant treatment * time effect in regard to opioid craving reduction.
← all excerpts
A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham.
1
—
—